Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
CRO
FDA asks for study do-overs at 2 CROs due to data concerns
The FDA has asked biopharmas to repeat studies they had already conducted at two CROs in India.
Kyle LaHucik
Sep 28, 2021 1:04pm
How a century-old TB vaccine may help fight severe COVID-19
Aug 4, 2021 2:00pm
Ocugen climbs on phase 3 COVID vaccine data
Jul 6, 2021 9:30am
OrbiMed collects $3.5B for a trio of life sciences, healthcare f
Mar 1, 2021 10:00am
ACG moves deeper into R&D with new investment in IQGEN-X
Nov 4, 2020 7:35am
Convalescent plasma fails phase 2 in moderate COVID-19 patients
Oct 23, 2020 8:25am